Skip to main content
logo
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.660
-0.350 (-6.99%)
At close: Aug 10, 2026, 4:00 PM EDT
4.670
+0.010 (0.21%)
Pre-market: Aug 11, 2026, 7:47 AM EDT

Lifecore Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 May '25 May '24 May '23 May '22 May '21
Net Income
-39.09-38.7212.01-99.56-116.72-32.29
Depreciation & Amortization
6.828.037.9513.1818.0619.87
Stock-Based Compensation
8.3610.166.23.612.613.36
Other Adjustments
31.0825.02-22.2145.5476.5515.78
Change in Receivables
-11.1-2.26-3.2610.82-6.145.78
Changes in Inventories
9.047.690.86-14.81-2.18-2.82
Changes in Accounts Payable
2.81-1.67-6.6816.049.34-5.98
Changes in Accrued Expenses
-8.8-5.921.65-0.49-3.424.08
Changes in Unearned Revenue
---6.08-0.020.43
Changes in Other Operating Activities
3.91-2.533.732.16-0.698.28
Operating Cash Flow
7.55-0.210.26-17.44-22.5916.47
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 May '25 May '24 May '23 May '22 May '21
Capital Expenditures
-7.14-13.42-18.4-21.48-29.94-25.22
Sale of Property, Plant & Equipment
-7--1.1412.91
Proceeds from Sale of Investments
----45.1-
Proceeds from Business Divestments
---16.6763.66-
Investing Cash Flow
-3.64-6.42-18.4-4.8179.96-12.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 May '25 May '24 May '23 May '22 May '21
Short-Term Debt Issued
106.75128.57149.5931.4555.11100
Short-Term Debt Repaid
-109.75-145.76-146.7-54.64-44.11-148.4
Net Short-Term Debt Issued (Repaid)
-3-17.192.88-23.1911-48.4
Long-Term Debt Issued
---15020170
Long-Term Debt Repaid
--0.93-0.71-123.69-86.41-114.13
Net Long-Term Debt Issued (Repaid)
--0.93-0.7126.31-66.4155.87
Issuance of Common Stock
-23.850.724.82--
Repurchase of Common Stock
-1.92-1.27-0.15-0.27-0.79-0.41
Net Common Stock Issued (Repurchased)
-1.9222.580.574.55-0.79-0.41
Issuance of Preferred Stock
---38.08--
Net Preferred Stock Issued (Repurchased)
---38.08--
Other Financing Activities
-0.941.974.77-6.05-0.82-10.48
Financing Cash Flow
-6.096.427.5139.7-57.02-3.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 May '25 May '24 May '23 May '22 May '21
Net Cash Flow
-0.82-0.2-10.6317.450.350.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 May '25 May '24 May '23 May '22 May '21
Free Cash Flow
0.4-13.62-18.14-38.92-52.53-8.75
Free Cash Flow Growth
------
FCF Margin
0.32%-10.57%-14.14%-37.69%-47.21%-8.68%
Free Cash Flow Per Share
0.01-0.39-0.49-1.30-1.78-0.30
Levered Free Cash Flow
-36.39-70.33.3-95.78-181.66-17.34
Unlevered Free Cash Flow
4.41-25.05-19.89-21.03-23.6-12.07
SEC Filings: 10-K · 10-Q